These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7051464)

  • 21. Blood transfusion in cadaveric renal transplantation-a prospective study.
    Frisk B; Brynger H; Wedel N; Sandberg L
    Scand J Urol Nephrol Suppl; 1981; 64():100-5. PubMed ID: 6755666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant blood transfusions revisited: a role for CD(4+) regulatory T cells?
    Roelen D; Brand A; Claas FH
    Transplantation; 2004 Jan; 77(1 Suppl):S26-8. PubMed ID: 14726766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood transfusions may induce anti-T cell receptor antibodies in renal patients.
    Fagnilli L; Singal DP
    Transplant Proc; 1982 Jun; 14(2):319-21. PubMed ID: 6180529
    [No Abstract]   [Full Text] [Related]  

  • 24. Beneficial effect of blood transfusion. Role of the time interval between the last transfusion and transplantation.
    Hourmant M; Soulillou JP; Bui-Quang D
    Transplantation; 1979 Jul; 28(1):40-3. PubMed ID: 377593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of blood transfusions on immune responsiveness.
    Kerman RH; Van Buren CT; Payne W; Flechner S; Agostino G; Conley S; Brewer E; Kahan BD
    Transplant Proc; 1982 Jun; 14(2):335-7. PubMed ID: 6214061
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful renal transplantation in a presensitized recipient after multiple blood transfusions.
    Barsoum RS; Kamel M; El-Khachab O; Hassaballa AM; Safwat M
    Clin Nephrol; 1980 Jul; 14(1):45-8. PubMed ID: 6996878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Suppression of proliferative allogenic response in patients receiving a programmed series of transfusions prior to renal graft].
    Comoy-Tournesac A; Nebout T; Mannoni P; Fradelizi D
    C R Seances Acad Sci III; 1981 Dec; 293(15):785-90. PubMed ID: 6804013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What has become of preliminary transfusion protocols in kidney transplantation?].
    Cartier F; Launois B; Campion JP; Chapuis B; Fauchet R
    Pathol Biol (Paris); 1987 Dec; 35(10):1316-20. PubMed ID: 3325891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
    Chia D; Horimi T; Terasaki PI; Hermes M
    Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two random transfusions before primary renal transplantation--four years' experience from a single center.
    Frisk B; Brynger H; Sandberg L
    Transplant Proc; 1982 Jun; 14(2):386-8. PubMed ID: 7051484
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of blood transfusions given after renal transplantation.
    Scornik JC; Schold JD; Bucci M; Meier-Kriesche HU
    Transplantation; 2009 May; 87(9):1381-6. PubMed ID: 19424040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.
    Waanders MM; Roelen DL; Brand A; Claas FH
    Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of matching for DR antigens and pretransplant blood transfusions on kidney graft survival in rhesus monkeys.
    Borleffs JC; Marquet RL; Neuhaus P
    Transplant Proc; 1982 Jun; 14(2):403-6. PubMed ID: 6214065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.